GRIESHEIM, Germany, March 3 /PRNewswire/ --

- Company Will Showcase its HughesNet(R) Enterprise VPN Solutions

Hughes Network Systems, LLC (HUGHES) announced today that its European operating unit is showcasing its comprehensive portfolio of HughesNet broadband solutions and managed services on March 4 - 9, 2008 at CeBIT 2008, booth E 33, Hall 13. Available continent-wide, the suite of HughesNet Managed Network Services means enterprises of all sizes can enjoy the benefits of high performance broadband connectivity at any number of locations, and including VPN solutions for optimized networks, high-availability networks and access continuity services.

HOLMDEL, New Jersey, March 3 /PRNewswire/ --

- Leading Russian Wireless Service Provider Deploys OnePlan Network Resource Planning to Reduce Backhaul Expenses and Strengthen Network for Next Generation Services

Call it Wireless 2.0. Seeing their voice service revenues plateau, wireless service providers are bringing a new generation of data services to market in the hopes of invigorating subscriber revenue growth (ARPU). Launching those new services, however, requires providers to strike a perfect balance between adding sufficient backhaul support to ensure a superior quality of experience (QoE) for users and minimizing backhaul expenses to grow net revenue and not just ARPU.

HANNOVER, Germany, March 3 /PRNewswire/ --

- Steve Ballmer discusses environmental sustainability efforts from Microsoft and general availability of enterprise products.

ANN ARBOR, Michigan, March 3 /PRNewswire/ --

Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO ) (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 )

BASINGSTOKE, England and PHILADELPHIA, Pennysylvania, March 3 /PRNewswire/ -- Shire plc (LSE: SHP)(NASDAQ: SHPGY), the global specialty biopharmaceutical company, notes that Renovo Group plc, (LSE: RNVO) ("Renovo") has today announced the results of Renovo's latest Phase 2 studies of JUVISTA(R) (human recombinant TGFbeta3) in scar revision surgery (RN1001-319-1009) and in breast augmentation (RN1001-319-1010).

Renovo’s press release can be found on http://www.renovo.com.

The two trials announced by Renovo are part of a broad global Phase 2 clinical program to assess the safety, efficacy, dose and dose frequency of JUVISTA in a variety of surgical procedures.

CANTON, Massachusetts, March 3 /PRNewswire/ --

- IML Enhances Audience Response System Offering and Technology in the US

Computershare Ltd. (ASX: CPU) announced today its continued international expansion of IML, a Computershare company, with the acquisition of Machine Dreams Inc.'s business. Under terms of the deal, Computershare will acquire the majority of the assets of Machine Dreams, an audience response specialist and IML distributor. IML is a leading supplier of audience response systems, which bring sophisticated interactive communications and data capture to events and meetings.

Although still relatively unknown to the general public, an archaeological method called a regional settlement pattern survey is being practiced at several locations around the world.

Rather than focusing on city centers and their easilt serviceable sites, it involves walking systematically over a large landscape to find traces of archaeological sites on the surface of the ground. This field procedure can yield a holistic, integrated view of how settlement has shifted in a region over the course of history.

For the past 13 years, archaeologists from The Field Museum and Shandong University have used this method to develop a multifarious overview of an important but understudied region along the northeastern coast of The People’s Republic of China.

Two cell proteins that relax the gut and help accommodate a big meal have been identified by UCL (University College London) scientists. The proteins could offer a future drug target against weight gain, by preventing the stomach from expanding.

In a Journal of Pharmacology and Experimental Therapeutics paper, Dr Brian King and Dr Andrea Townsend-Nicholson explored the molecular basis of relaxations of the gut. In the study, the authors identified two protein receptors – P2Y1 and P2Y11 – involved in fast and slow relaxations of the gut. These proteins were identified in the guinea pig, but are also present in the human gut, and thus offer the potential as a future target for drug treatment.

HELSINKI, March 3 /PRNewswire/ -- Wärtsilä has been awarded two contracts by Scottish and Newcastle (S&N), the major international brewing group, to supply and install equipment for two biomass-fuelled combined heat and power plants (CHP). The contracts are for two CHP plants to be located on the premises of the company's UK breweries in Manchester, for which the order was received in the end of 2007, and Tadcaster, for which the order was received in the beginning of 2008.

These Wärtsilä BioPower plants will be the first power plants in the world ever to produce, with high efficiency, both electricity and heat using spent grain as fuel. Spent grain is a by-product of the brewing process.

LONDON, March 3 /PRNewswire/ -- Manpower Software plc, a leading provider of workforce optimisation and electronic rostering solutions, is pleased to announce that Northern Devon Healthcare NHS Trust, the largest employer in the area, has selected Manpower Software's MAPS Healthroster solution to more effectively manage its nursing staff, with the intention of eventual roll-out to other staff groups in the organisation.

Carolyn Mills, Director of Nursing at Northern Devon Healthcare commented: "We chose MAPS Healthroster after assessing its use on a number of wards. Staff found it easy to use and it made their lives simpler, with less paperwork. By implementing Manpower Software's MAPS Healthroster solution we anticipate both financial and qualitative benefits. "